MARRIOTT VACATIONS WORLDWIDE Corp
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-11-06.
0001524358-25-000166
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-05.
0001524358-26-000022
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 12 previous paragraphs and 9 current paragraphs.
6 unchanged; 3 reworded; 0 added; 3 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to the risk factors set forth in Item 1A of Part 1 of our 2025 Annual Report, except to the extent factual information disclosed elsewhere in this Quarterly Report relates to such risk factors, which is incorporated herein by reference.
Removed paragraphs (3)
Previous report
During the quarter ended September 30, 2025, the following officers and directors, as defined in Rule 16a-1(f), adopted a “Rule 10b5-1 trading arrangement” as defined in Regulation S-K Item 408, as follows:
Previous report
On September 11, 2025, John E. Geller, Jr., the Company’s President and Chief Executive Officer and a member of the Board of Directors of the Company, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (“Rule 10b5-1(c)”). Mr. Geller’s trading plan provides for the acquisition of up to 20,471 shares of the Company’s common stock upon the exercise of stock appreciation rights, less any shares to be withheld and/or sold to satisfy applicable tax withholdings, and the sale of the net shares acquired over the term of the plan. Potential transactions under Mr. Geller’s trading plan are subject to the occurrence and satisfaction of certain stock price and/or other conditions. The trading arrangement will expire on the earlier of March 2, 2026, or the completion of all transactions subject to the trading arrangement.
Previous report
On September 25, 2025, James H Hunter, IV, the Company’s Executive Vice President, General Counsel and Secretary, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Mr. Hunter’s trading plan provides for the potential acquisition of up to 7,444 shares of the Company’s common stock issuable upon the exercise of stock appreciation rights over the term of the plan, less any shares to be withheld and/or sold to satisfy applicable tax withholdings. Potential acquisitions under Mr. Hunter’s trading plan are subject to the occurrence and satisfaction of certain stock price and/or other conditions. The trading arrangement will expire on the earlier of March 2, 2026, or the completion of all transactions subject to the trading arrangement.
Reworded paragraphs (3)
Previous wording
There have been no material changes to the risk factors set forth in Item 1A of Part 1 of our 2024 Annual Report and in Item 1A of Part II of our Quarterly Report for the quarter ended June 30, 2025, except to the extent factual information disclosed elsewhere in this Quarterly Report relates to such risk factors, which is incorporated herein by reference.
Current wording
There have been no material changes to the risk factors set forth in Item 1A of Part 1 of our 2025 Annual Report, except to the extent factual information disclosed elsewhere in this Quarterly Report relates to such risk factors, which is incorporated herein by reference.
Previous wording
(1)On May 11, 2023, we announced that our Board of Directors increased the then-remaining authorization under our share repurchase program (which was first announced on September 13, 2021) to authorize purchases of up to $600 million of our common stock and extended the term of our share repurchase program to December 31, 2024. On December 19, 2024, we announced that our Board of Directors extended the term of our share repurchase program to December 31, 2025.
Current wording
(1)On May 11, 2023, we announced that our Board of Directors increased the then-remaining authorization under our share repurchase program (which was first announced on September 13, 2021) to authorize purchases of up to $600 million of our common stock and extended the term of our share repurchase program to December 31, 2024. On December 19, 2024, we announced that our Board of Directors extended the term of our share repurchase program to December 31, 2025. On December 12, 2025, we announced that our Board of Directors extended the term of our share repurchase program to December 31, 2026.
Previous wording
During the quarter ended September 30, 2025, no other directors or officers, as defined in Rule 16a-1(f), adopted orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408.
Current wording
During the quarter ended March 31, 2026, no director or Section 16 officer adopted orterminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).